Kala Bio (KALA) Prepaid Assets (2016 - 2026)
Kala Bio (KALA) posted Prepaid Assets of $3.6 million for Q1 2026, up 126.37% sequentially from $1.6 million in Q4 2025, and up 1192.36% YoY from $275000.0 in Q1 2025.
Kala Bio (KALA) Prepaid Assets (2016 - 2026) Analysis & Trends
Kala Bio has reported Prepaid Assets for 11 years, with the latest figure at $3.6 million in Q1 2026.
- Quarterly Prepaid Assets rose 1192.36% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 1192.36% YoY) and the FY2025 annual result came in at $1.6 million, down 2.85% from the prior year.
- Prepaid Assets climbed to $3.6 million in Q1 2026 per KALA's latest filing, from $1.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $22.6 million in Q3 2022 and troughed at $99000.0 in Q3 2025.
- A 5-year average of $3.1 million and a median of $1.6 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets plunged 97.13% in 2023, then surged 1192.36% in 2026.
- Over 5 years, Prepaid Assets stood at $698000.0 in 2022, then jumped by 182.95% to $2.0 million in 2023, then slipped by 18.18% to $1.6 million in 2024, then retreated by 2.85% to $1.6 million in 2025, then jumped by 126.37% to $3.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.6 million, $1.6 million, and $99000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kala Bio | 9.89 Mn | 9.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 380,000.00 |
| Mar 31, 2025 | 275,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 649,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 2.35 Mn |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 22.58 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 6.20 Mn |
| Sep 30, 2021 | 4.25 Mn |
| Jun 30, 2021 | 2.18 Mn |